Symbols / CPHI $0.65 -1.20% China Pharma Holdings, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • China • ASE
CPHI Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection for edema diseases, hypertension, acute renal failure, hyperkalemia, hypercalcemia, and acute drug poisoning; and Candesartan for hypertension. It offers Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and Pseudophedrine Hydrochlorida sustained release tablets. It offers Hepatocyte growth-promoting factors, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection for nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It supplies its products to hospitals and OTC pharmacies through provincial and municipal pharmaceutical logistics companies. The company is based in Haikou, the People's Republic of China.

Fundamentals
Scroll to Statements
Market Cap 26.27M Enterprise Value 30.13M Income -3.19M Sales 4.14M Book/sh 1.47 Cash/sh 0.01
Dividend Yield — Payout 0.00% Employees 215 IPO — P/E — Forward P/E —
PEG 0.16 P/S 6.34 P/B 0.44 P/C — EV/EBITDA -19.02 EV/Sales 7.27
Quick Ratio 0.09 Current Ratio 0.32 Debt/Eq 17.09 LT Debt/Eq — EPS (ttm) -0.74 EPS next Y —
EPS Growth — Revenue Growth 8.10% Earnings 2011-11-10 ROA -8.41% ROE -20.91% ROIC —
Gross Margin -3.18% Oper. Margin -97.86% Profit Margin -76.92% Shs Outstand 40.52M Shs Float 37.84M Short Float 0.04%
Short Ratio 0.44 Short Interest — 52W High 2.60 52W Low 0.50 Beta 1.09 Avg Volume 45.37K
Volume 8.76K Target Price — Recom None Prev Close $0.66 Price $0.65 Change -1.20%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.65
Latest analyst target
3. DCF / Fair value
$0.47
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.65
Low
—
High
—
Mean
—
News
RSS: Latest CPHI news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
4.14
-8.49%
4.53
-35.41%
7.01
-13.48%
8.10
Operating Revenue
4.14
-8.49%
4.53
-35.41%
7.01
-13.48%
8.10
Cost Of Revenue
4.28
-34.36%
6.51
-10.67%
7.29
-15.19%
8.60
Reconciled Cost Of Revenue
4.28
-34.36%
6.51
-10.67%
7.29
-15.19%
8.60
Gross Profit
-0.13
+93.35%
-1.99
-606.42%
-0.28
+43.09%
-0.49
Operating Expense
2.96
+13.82%
2.60
+4.47%
2.49
-21.04%
3.15
Research And Development
0.28
-1.07%
0.28
+18.27%
0.24
+29.17%
0.19
Selling General And Administration
2.83
+22.20%
2.31
+2.99%
2.25
-24.19%
2.96
Selling And Marketing Expense
0.38
-28.94%
0.53
-32.23%
0.78
-27.06%
1.07
General And Administrative Expense
2.45
+37.36%
1.78
+21.74%
1.47
-22.56%
1.89
Other Gand A
2.45
+37.36%
1.78
+21.74%
1.47
-22.56%
1.89
Other Operating Expenses
-0.15
—
—
—
Total Expenses
7.23
-20.62%
9.11
-6.82%
9.78
-16.75%
11.75
Operating Income
-3.09
+32.61%
-4.58
-65.60%
-2.77
+24.03%
-3.64
Total Operating Income As Reported
-3.24
+29.41%
-4.59
-66.76%
-2.75
+22.46%
-3.55
EBITDA
-1.51
+20.94%
-1.91
-22687.17%
0.01
+101.01%
-0.84
Normalized EBITDA
-1.51
+20.65%
-1.90
-25842.72%
-0.01
+99.21%
-0.93
Reconciled Depreciation
1.58
-41.01%
2.68
-2.78%
2.75
+1.97%
2.70
EBIT
-3.09
+32.66%
-4.58
-66.92%
-2.75
+22.41%
-3.54
Total Unusual Items
0.00
+117.85%
-0.01
-136.19%
0.02
-83.21%
0.09
Total Unusual Items Excluding Goodwill
0.00
+117.85%
-0.01
-136.19%
0.02
-83.21%
0.09
Special Income Charges
0.00
+117.85%
-0.01
-136.19%
0.02
-83.21%
0.09
Write Off
-0.00
-117.85%
0.01
+136.19%
-0.02
+83.21%
-0.09
Net Income
-3.19
+32.70%
-4.74
-53.84%
-3.08
+22.50%
-3.97
Pretax Income
-3.19
+32.70%
-4.74
-53.84%
-3.08
+22.50%
-3.97
Net Non Operating Interest Income Expense
-0.10
+32.18%
-0.15
+54.89%
-0.33
+22.85%
-0.42
Interest Expense Non Operating
0.10
-33.80%
0.15
-53.79%
0.33
-23.24%
0.43
Net Interest Income
-0.10
+32.18%
-0.15
+54.89%
-0.33
+22.85%
-0.42
Interest Expense
0.10
-33.80%
0.15
-53.79%
0.33
-23.24%
0.43
Interest Income Non Operating
0.00
-69.84%
0.01
+0.59%
0.01
-38.61%
0.01
Interest Income
0.00
-69.84%
0.01
+0.59%
0.01
-38.61%
0.01
Other Income Expense
0.00
+117.85%
-0.01
-136.19%
0.02
-83.21%
0.09
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-3.19
+32.70%
-4.74
-53.84%
-3.08
+22.50%
-3.97
Net Income From Continuing Operation Net Minority Interest
-3.19
+32.70%
-4.74
-53.84%
-3.08
+22.50%
-3.97
Net Income From Continuing And Discontinued Operation
-3.19
+32.70%
-4.74
-53.84%
-3.08
+22.50%
-3.97
Net Income Continuous Operations
-3.19
+32.70%
-4.74
-53.84%
-3.08
+22.50%
-3.97
Normalized Income
-3.19
+32.60%
-4.73
-52.87%
-3.09
+23.90%
-4.07
Net Income Common Stockholders
-3.19
+32.70%
-4.74
-53.84%
-3.08
+22.50%
-3.97
Diluted EPS
-7.40
+72.69%
-27.10
-197.80%
-9.10
+75.93%
-37.80
Basic EPS
-7.40
+72.69%
-27.10
-197.80%
-9.10
+75.93%
-37.80
Basic Average Shares
0.43
+145.73%
0.17
-48.39%
0.34
+221.82%
0.11
Diluted Average Shares
0.43
+145.73%
0.17
-48.39%
0.34
+221.82%
0.11
Diluted NI Availto Com Stockholders
-3.19
+32.70%
-4.74
-53.84%
-3.08
+22.50%
-3.97
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
31.00
+108.22%
14.89
-9.60%
16.47
-7.39%
17.78
Current Assets
2.35
-28.25%
3.27
-45.47%
6.00
+0.54%
5.96
Cash Cash Equivalents And Short Term Investments
0.35
-44.95%
0.63
-55.97%
1.42
-29.86%
2.03
Cash And Cash Equivalents
0.35
-44.95%
0.63
-55.97%
1.42
-29.86%
2.03
Receivables
0.29
+3.42%
0.28
-61.41%
0.73
+56.81%
0.46
Accounts Receivable
0.24
+3.99%
0.23
-53.98%
0.50
+19.67%
0.42
Gross Accounts Receivable
0.25
-98.16%
13.82
-3.30%
14.29
-16.73%
17.16
Allowance For Doubtful Accounts Receivable
-0.01
+99.90%
-13.59
+1.44%
-13.79
+17.64%
-16.74
Other Receivables
0.05
+62.65%
0.03
-80.82%
0.16
+442.04%
0.03
Inventory
1.62
-28.45%
2.27
-39.29%
3.73
+26.62%
2.95
Raw Materials
0.84
-4.20%
0.88
-53.30%
1.89
+2.50%
1.84
Work In Process
0.46
+34.49%
0.34
-17.70%
0.41
-25.77%
0.56
Finished Goods
1.47
-9.51%
1.62
+3.62%
1.56
+183.62%
0.55
Prepaid Assets
0.09
-7.36%
0.10
-14.24%
0.11
-78.51%
0.52
Total Non Current Assets
28.65
+146.64%
11.62
+10.93%
10.47
-11.40%
11.82
Net PPE
4.17
-7.88%
4.53
-33.57%
6.82
-29.02%
9.61
Gross PPE
37.66
+2.82%
36.63
-1.57%
37.21
-1.96%
37.96
Accumulated Depreciation
-33.49
-4.33%
-32.10
-5.61%
-30.39
-7.21%
-28.35
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
9.31
+2.27%
9.10
-1.47%
9.23
-1.67%
9.39
Machinery Furniture Equipment
28.18
+2.49%
27.49
-1.33%
27.86
-2.33%
28.53
Other Properties
0.18
+374.77%
0.04
-67.16%
0.12
+198.65%
0.04
Goodwill And Other Intangible Assets
24.48
+245.41%
7.09
+94.02%
3.65
+65.15%
2.21
Other Intangible Assets
24.48
+245.41%
7.09
+94.02%
3.65
+65.15%
2.21
Total Liabilities Net Minority Interest
8.26
+15.69%
7.14
-20.80%
9.01
-33.20%
13.49
Current Liabilities
7.40
+47.50%
5.02
-26.44%
6.82
-46.46%
12.74
Payables And Accrued Expenses
1.59
+74.49%
0.91
-60.16%
2.29
-25.80%
3.09
Payables
1.24
+86.59%
0.67
-66.58%
1.99
-25.74%
2.68
Accounts Payable
0.89
+295.85%
0.23
-76.71%
0.97
+44.87%
0.67
Other Payable
—
—
1.24
+30.69%
0.95
Current Accrued Expenses
0.35
+41.87%
0.25
-17.29%
0.30
-26.18%
0.40
Pensionand Other Post Retirement Benefit Plans Current
1.92
+20.91%
1.59
+26.44%
1.26
+236.98%
0.37
Total Tax Payable
0.35
-20.21%
0.44
-57.06%
1.03
-3.64%
1.07
Current Debt And Capital Lease Obligation
3.78
+60.38%
2.35
-26.02%
3.18
-63.66%
8.76
Current Debt
3.70
+60.01%
2.31
-25.43%
3.10
-64.38%
8.72
Other Current Borrowings
3.70
+60.01%
2.31
-25.43%
3.10
-64.38%
8.72
Current Capital Lease Obligation
0.07
+82.15%
0.04
-49.41%
0.08
+92.18%
0.04
Current Deferred Liabilities
0.11
-31.21%
0.16
+79.22%
0.09
-82.60%
0.52
Current Deferred Revenue
0.11
-31.21%
0.16
+79.22%
0.09
-82.60%
0.52
Total Non Current Liabilities Net Minority Interest
0.86
-59.51%
2.12
-3.26%
2.19
+190.70%
0.75
Long Term Debt And Capital Lease Obligation
0.11
-91.98%
1.39
-4.18%
1.45
0.00
Long Term Debt
—
1.39
-1.47%
1.41
—
Long Term Capital Lease Obligation
0.11
0.00
-100.00%
0.04
0.00
Non Current Deferred Liabilities
0.75
+2.27%
0.73
-1.47%
0.74
-1.67%
0.75
Non Current Deferred Taxes Liabilities
0.75
+2.27%
0.73
-1.47%
0.74
-1.67%
0.75
Stockholders Equity
22.74
+193.50%
7.75
+3.93%
7.45
+73.77%
4.29
Common Stock Equity
22.74
+193.50%
7.75
+3.93%
7.45
+73.77%
4.29
Capital Stock
0.02
+375.84%
0.00
-69.30%
0.01
+609.28%
0.00
Common Stock
0.02
+375.84%
0.00
-69.30%
0.01
+609.28%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
5.02
+53.96%
3.26
+206.98%
1.06
+609.25%
0.15
Ordinary Shares Number
5.02
+53.96%
3.26
+206.98%
1.06
+609.25%
0.15
Additional Paid In Capital
58.54
+44.06%
40.63
+15.16%
35.28
+21.97%
28.93
Retained Earnings
-47.21
-7.24%
-44.03
-12.05%
-39.29
-8.50%
-36.21
Gains Losses Not Affecting Retained Earnings
11.58
+2.32%
11.32
-1.16%
11.45
-1.05%
11.57
Other Equity Adjustments
11.58
+2.32%
11.32
-1.16%
11.45
-1.05%
11.57
Total Equity Gross Minority Interest
22.74
+193.50%
7.75
+3.93%
7.45
+73.77%
4.29
Total Capitalization
22.74
+148.82%
9.14
+3.07%
8.87
+106.68%
4.29
Working Capital
-5.05
-189.31%
-1.75
-112.07%
-0.82
+87.84%
-6.77
Invested Capital
26.44
+130.87%
11.45
-4.32%
11.97
-7.96%
13.01
Total Debt
3.89
+3.79%
3.75
-19.18%
4.63
-47.08%
8.76
Net Debt
3.36
+9.08%
3.08
-0.43%
3.09
-53.75%
6.69
Capital Lease Obligations
0.18
+365.82%
0.04
-66.57%
0.12
+190.86%
0.04
Net Tangible Assets
-1.74
-363.42%
0.66
-82.62%
3.80
+82.94%
2.08
Tangible Book Value
-1.74
-363.42%
0.66
-82.62%
3.80
+82.94%
2.08
Inventories Adjustments Allowances
-1.15
-99.49%
-0.57
-343.57%
-0.13
—
Line Of Credit
—
—
—
—
Notes Receivable
0.00
-100.00%
0.02
-71.72%
0.07
+378.20%
0.01
Other Equity Interest
-0.18
+0.00%
-0.18
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
0.15
+136.51%
-0.41
+41.96%
-0.70
-70.84%
-0.41
Cash Flow From Continuing Operating Activities
0.15
+136.51%
-0.41
+41.96%
-0.70
-70.84%
-0.41
Net Income From Continuing Operations
-3.19
+32.70%
-4.74
-53.84%
-3.08
+22.50%
-3.97
Depreciation Amortization Depletion
1.58
-41.01%
2.68
-2.78%
2.75
+1.97%
2.70
Depreciation
0.73
-67.37%
2.23
-11.86%
2.53
-5.03%
2.66
Amortization Cash Flow
0.85
+90.41%
0.45
+99.85%
0.22
+512.17%
0.04
Depreciation And Amortization
1.58
-41.01%
2.68
-2.78%
2.75
+1.97%
2.70
Amortization Of Intangibles
0.85
+90.41%
0.45
+99.85%
0.22
+512.17%
0.04
Other Non Cash Items
0.00
+57.53%
0.00
+113.99%
-0.02
—
Stock Based Compensation
—
—
0.00
-100.00%
0.08
Asset Impairment Charge
-13.12
-2973.71%
0.46
+5824.10%
-0.01
+91.50%
-0.09
Operating Gains Losses
—
—
0.05
—
Gain Loss On Sale Of PPE
—
0.00
-100.00%
0.05
0.00
Change In Working Capital
14.87
+1144.70%
1.19
+401.55%
-0.40
-145.10%
0.88
Change In Receivables
13.21
+6780.77%
-0.20
+78.92%
-0.94
-451.15%
-0.17
Change In Inventory
0.59
-63.30%
1.61
+9520.14%
-0.02
-102.48%
0.69
Change In Prepaid Assets
0.01
-36.91%
0.01
-96.49%
0.41
+185.07%
-0.48
Change In Payables And Accrued Expense
1.12
+468.70%
-0.30
-153.12%
0.57
+12.96%
0.50
Change In Payable
1.12
+468.70%
-0.30
-153.12%
0.57
+12.96%
0.50
Change In Account Payable
0.65
+188.61%
-0.73
-335.20%
0.31
+266.22%
-0.19
Change In Other Working Capital
-0.05
-172.50%
0.07
+117.42%
-0.42
-224.61%
0.34
Change In Other Current Liabilities
—
—
—
—
Investing Cash Flow
-0.14
+52.95%
-0.29
-2432.93%
-0.01
+97.13%
-0.40
Cash Flow From Continuing Investing Activities
-0.14
+52.95%
-0.29
-2432.93%
-0.01
+97.13%
-0.40
Net PPE Purchase And Sale
-0.06
-54.45%
-0.04
-233.52%
-0.01
+97.13%
-0.40
Purchase Of PPE
-0.06
-54.45%
-0.04
-233.52%
-0.01
+97.13%
-0.40
Capital Expenditure
-0.14
+52.95%
-0.29
-2432.93%
-0.01
+97.13%
-0.40
Net Intangibles Purchase And Sale
-0.08
+69.24%
-0.25
0.00
—
Purchase Of Intangibles
-0.08
+69.24%
-0.25
0.00
—
Financing Cash Flow
-0.29
-770.37%
-0.03
-146.18%
0.07
+104.13%
-1.77
Cash Flow From Continuing Financing Activities
-0.29
-770.37%
-0.03
-146.18%
0.07
+104.13%
-1.77
Net Issuance Payments Of Debt
-0.29
-770.37%
-0.03
-146.18%
0.07
+104.73%
-1.55
Issuance Of Debt
0.96
+84.78%
0.52
-66.73%
1.56
+163.20%
0.59
Repayment Of Debt
-1.26
-126.59%
-0.55
+62.83%
-1.49
+30.40%
-2.14
Long Term Debt Issuance
0.96
+84.78%
0.52
-66.73%
1.56
+163.20%
0.59
Long Term Debt Payments
-1.26
-126.59%
-0.55
+62.83%
-1.49
+30.40%
-2.14
Net Long Term Debt Issuance
-0.29
-770.37%
-0.03
-146.18%
0.07
+104.73%
-1.55
Short Term Debt Issuance
—
—
0.03
+5.56%
0.03
Short Term Debt Payments
—
—
—
-2.14
Net Short Term Debt Issuance
—
—
0.03
+5.56%
0.03
Net Other Financing Charges
—
—
—
-0.22
Changes In Cash
-0.28
+61.31%
-0.73
-14.65%
-0.64
+75.28%
-2.58
Effect Of Exchange Rate Changes
0.00
+101.91%
-0.07
-304.84%
0.03
+112.90%
-0.25
Beginning Cash Position
0.63
-55.97%
1.42
-29.86%
2.03
-58.22%
4.86
End Cash Position
0.35
-44.95%
0.63
-55.97%
1.42
-29.86%
2.03
Free Cash Flow
0.01
+101.58%
-0.70
+1.89%
-0.71
+12.36%
-0.81
Interest Paid Supplemental Data
0.07
-13.83%
0.09
-6.14%
0.09
-34.81%
0.14
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category